Skip to content

Clinical trials

Neoplasm Metastasis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: Netherlands Clear all

206 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20024
20031
20044
20051
20066
20076
20085
20094
20106
201110
20128
20139
201415
201512
20168
20178
20185
201915
20209
202118
202213
20239
20249
20258
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed91
Terminated37
Recruiting29
Active, not recruiting26
Unknown status18
Withdrawn4
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals15
AstraZeneca12
Eli Lilly and Company9
The Netherlands Cancer Institute9
UMC Utrecht9
European Organisation for Research and Treatment of Cancer - EORTC8
Amsterdam UMC, location VUmc7
Sanofi7
Maastricht University Medical Center6
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis206
Neoplasms36
Breast Neoplasms30
Carcinoma, Non-Small-Cell Lung28
Colorectal Neoplasms23
Prostatic Neoplasms17
Lung Neoplasms12
Melanoma11
Recurrence11
Brain Neoplasms9

Trials

Showing 1 to 25 of 206. Each trial links to its page on Pharma Observatory.

106 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.